1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Market Dynamics 6.1 Drivers 6.1.1 Rising Geriatric Population 6.1.2 Growing Technological Advancements in Personalized Medicines 6.1.3 Rising Awareness Through Campaigns 6.2 Restraints 6.2.1 Rising Preference Towards Minimally Invasive Surgeries 6.2.2 Non-adherence of Patients to Pharmacological Therapy 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Drug Type 7.1.1 Alpha-Blockers 7.1.2 5- Alpha-Reductase Inhibitors (5-Aris) 7.1.3 Alpha-Adrenergic Blockers 7.1.4 Phosphodiesterase-5 Enzyme Inhibitors 7.1.5 Others 7.2 By Distribution Channel 7.2.1 Hospital Pharmacies 7.2.2 Retail Pharmacies 7.2.3 Online Pharmacies 7.3 By Geography 7.3.1 North America 7.3.1.1 US 7.3.1.2 Canada 7.3.1.3 Mexico 7.3.2 Europe 7.3.2.1 France 7.3.2.2 Germany 7.3.2.3 UK 7.3.2.4 Italy 7.3.2.5 Spain 7.3.2.6 Rest of Europe 7.3.3 Asia-Pacific 7.3.3.1 China 7.3.3.2 Japan 7.3.3.3 India 7.3.3.4 Australia 7.3.3.5 South Korea 7.3.3.6 Rest of Asia-Pacific 7.3.4 Middle East & Africa 7.3.4.1 GCC 7.3.4.2 South Africa 7.3.4.3 Rest of MEA 7.3.5 South America 7.3.5.1 Brazil 7.3.5.2 Argentina 7.3.5.3 Rest of South America 8. Competitive Landscape 8.1 Mergers & Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Allergan PLC 9.2 Astellas Pharma Inc. 9.2 Boehringer Ingelheim 9.4 Eli Lilly and Company 9.5 GlaxoSmithKline PLC 9.6 Nymox Pharmaceutical Corporation 9.7 Pfizer, Inc 9.8 Sanofi 9.9 Sophiris Bio Corp 9.10 Teva Pharmaceutical Industries Limited * List Not Exhaustive 10. Future of the Market

Allergan PLC, Astellas Pharma Inc., Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline PLC, Nymox Pharmaceutical Corporation, Pfizer, Inc, Sanofi, Sophiris Bio Corp, and Teva Pharmaceutical Industries Limited, among others.